You are now leaving the Kedrion Corporate site. The information available in your chosen website may not be in compliance with EU legislation regulating the advertising of medicinal products for human use, nor do the opinions expressed necessarily reflect the Company’s positions or are endorsed by it.
NO
YES
NEWS / EVENTS / .........

EVENTS - 14-07-2017

Kedrion Biopharma attends XXVI ISTH Congress in Berlin, Germany

Over 8,000 experts from all over the world participated in the ISTH – International Society on Thrombosis and Haemostasis Biannual Congress, the most important global event dedicated to thrombosis, hemostasis and vascular biology, which this year was held in Berlin, Germany on July 8-13. Inhibitors and customized prophylaxis were the topics discussed the most by hemostasis KOLs attending the event.

Kedrion Biopharma attended with a booth and a large delegation of international guests. The company also organized the symposium SIPPET Study: One Year Later. New Insights to Help Manage “My Next Patient”, chaired by Prof. Flora Peyvandi on 9 July. Starting with an overview of the SIPPET study, and moving on to examine the reactions to it published by the different communities of stakeholders and the sub-analyses ensuing from it, the event closed with a round table aimed at encouraging the audience to reflect on how the study’s results could be integrated into the decision-making process concerning the therapeutic choices available for Previously Untreated Patients.

Moreover, Kedrion contributed to Octapharma’s symposium Towards Life Without Limitations: Growing Experience with Nuwiq® in Patients with Hemophilia A, which was held on the same day. Chaired by Prof. Pier Mannuccio Mannucci, it featured a lecture by Dr. Massimo Morfini reporting data on the use of the product to carry out personalized prophylaxis in Italy.

For more information please contact: pressoffice@kedrion.com